Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination

Cited by (1,001)

Items 101–200 of 1,001

1. Vaccinations and Autoimmune Diseases
   Bianca Olivieri, Corrado Betterle, Giovanna Zanoni · 2021 · Vaccines
2. Mental Health Issues During and After COVID-19 Vaccine Era
   K. Pandey, M. Thurman, S. Johnson, A. Acharya, Morgan P. Johnston, Elizabeth Klug, Omalla A. Olwenyi, R. Rajaiah, S. Byrareddy · 2021 · Brain Research Bulletin
3. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
   Mayte Sánchez van Kammen, Diana Aguiar de Sousa, Sven Poli, Charlotte Cordonnier, Mirjam R. Heldner, Anita A. G. A. van de Munckhof, Katarzyna Krzywicka, Thijs F. van Haaps, Alfonso Ciccone, Saskia Middeldorp et al. · 2021 · JAMA Neurology
4. Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
   Dvir Gatt, Isaac Martin, Rawan AlFouzan, Theo J. Moraes · 2023 · Pathogens
5. PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia
   Caroline Vayne, Jérôme Rollin, Yves Gruel, Claire Pouplard, Hubert Galinat, Olivier Huet, Vincent Mémier, Thomas Geeraerts, Raphaël Marlu, Gilles Pernod et al. · 2021 · New England Journal of Medicine
6. Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine
   Swathi S. Sangli, Ahmed Virani, Nicholas Cheronis, Brittany Vannatter, Corbyn Minich, Shaun Noronha, Rama Bhagavatula, Daniel Speredelozzi, Meera Sareen, Robert B. Kaplan · 2021 · Annals of Internal Medicine
7. Rheumatological complications of Covid 19
   Hannah Zacharias, Shirish Dubey, Gouri Koduri, David P. D’Cruz · 2021 · Autoimmunity Reviews
8. Postvaccinal Encephalitis after ChAdOx1 nCov ‐19
   Frédéric Zuhorn, Tilmann Graf, Randolf Klingebiel, Wolf‐Rüdiger Schäbitz, Andreas Rogalewski · 2021 · Annals of Neurology
9. Clinical use of thrombin generation assays
   Nikolaus B. Binder, François Depasse, Julia Müeller, Thomas Wissel, Stephan Schwers, Matthias Germer, Björn Hermes, Peter L. Turecek · 2021 · Journal of Thrombosis and Haemostasis
10. Sexual dimorphism in COVID-19: potential clinical and public health implications
    Nicole Bechmann, Andreas Barthel, Andreas Schedl, Stephan Herzig, Zsuzsanna Varga, Cathérine Gebhard, Manuel Mayr, Constanze Hantel, Felix Beuschlein, Christian Wolfrum et al. · 2022 · Publikationen an der Universität Bielefeld (Universität Bielefeld)
11. Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)
    J. Thaler, Cihan Ay, Karoline Veronika Gleixner, Alexander W. Hauswirth, Filippo Cacioppo, Juergen Grafeneder, Peter Quehenberger, Ingrid Pabinger, Paul Knöbl · 2021 · Journal of Thrombosis and Haemostasis
12. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis
    John G. Rizk, Aashish Anand Gupta, Partha Sardar, Brandon Michael Henry, John C. Lewin, Giuseppe Lippi, Carl J. Lavie · 2021 · JAMA Cardiology
13. Sexual dimorphism in COVID-19: potential clinical and public health implications
    Nicole Bechmann, Andreas Barthel, Andreas Schedl, Stephan Herzig, Zsuzsanna Varga, Cathérine Gebhard, Manuel Mayr, Constanze Hantel, Felix Beuschlein, Christian Wolfrum et al. · 2022 · The Lancet Diabetes & Endocrinology
14. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia
    Theodore Earl Warkentin, Andreas Greinacher · 2021 · Thrombosis Research
15. Viral Vector Vaccine Development and Application during the COVID-19 Pandemic
    Shaofeng Deng, Hui Liang, Chen Pin, Yuwan Li, Zhaoyao Li, Shuangqi Fan, Keke Wu, Xiaowen Li, Wenxian Chen, Yuwei Qin et al. · 2022 · Microorganisms
16. The COVID-19 pandemic: viral variants and vaccine efficacy
    Marco Ciotti, Massimo Ciccozzi, Massimo Pieri, Sergio Bernardini · 2021 · Critical Reviews in Clinical Laboratory Sciences
17. A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences
    Tarun Tyagi, Kanika Jain, Sean X. Gu, Miaoyun Qiu, Vivian W. Gu, Hannah Camille Melchinger, Henry M. Rinder, Kathleen A. Martin, Elizabeth E. Gardiner, Alfred Ian Lee et al. · 2022 · Nature Cardiovascular Research
18. An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
    Han-Qi Zhang, Buzi Cao, Qingtai Cao, Marady Hun, Lin Cao, Mingyi Zhao · 2023 · Human Vaccines & Immunotherapeutics
19. Trust and COVID-19 vaccine hesitancy
    Vincenzo Carrieri, Sophie Guthmuller, Ansgar Wübker · 2023 · Scientific Reports
20. An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination
    Ingvild Hausberg Sørvoll, Kjersti Daae Horvei, Siw Leiknes Ernstsen, Ingvild Jenssen Lægreid, Svetlana Lund, Renathe Henriksen Grønli, Magnus Kringstad Olsen, Hege Karine Jacobsen, Anna Eriksson, Anne Marie Halstensen et al. · 2021 · Journal of Thrombosis and Haemostasis
21. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines
    Brit Long, Rachel E Bridwell, Michael A. Gottlieb · 2021 · The American Journal of Emergency Medicine
22. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V)
    Arvind Nune, Karthikeyan Parthasarathy Iyengar, Christopher Goddard, Ashar E Ahmed · 2021 · BMJ Case Reports
23. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
    Sara E. Oliver, Megan M. Wallace, Isaac See, Sarah A. Mbaeyi, Monica Godfrey, Stephen C. Hadler, Tara C. Jatlaoui, Evelyn Twentyman, Michelle M. Hughes, Agam K. Rao et al. · 2022 · MMWR Morbidity and Mortality Weekly Report
24. Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins
    Nunez-Castilla, Janelle, Stebliankin, Vitalii, Baral, Prabin, Balbin, Christian A., Sobhan, Masrur, Cickovski, Trevor, Mondal, Ananda Mohan, Narasimhan, Giri, Chapagain, Prem, Mathee, Kalai et al. · 2022 · Viruses
25. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
    Lewis Au, Annika Fendler, Scott Thomas Colville Shepherd, Karolina Rzeniewicz, Maddalena Cerrone, Fiona Byrne, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, John C Shon et al. · 2021 · Nature Medicine
26. Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis
    Sisse Rye Ostrowski, Ole Schmeltz Søgaard, Martin Tolstrup, Nina Breinholt Stærke, Jens Dilling Lundgren, Lars Jørgen Østergaard, Anne‐Mette Hvas · 2021 · Frontiers in Immunology
27. Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials
    Steven Kwasi Korang, Elena von Rohden, Areti Angeliki Veroniki, Giok Ong, Owen Ngalamika, Faiza Siddiqui, Sophie Juul, Emil Eik Nielsen, Joshua Buron Feinberg, Johanne Juul Petersen et al. · 2022 · PLoS ONE
28. Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency
    Katarzyna Krzywicka, Mirjam R. Heldner, Mayte Sánchez van Kammen, Thijs F. van Haaps, Sini Hiltunen, Suzanne M. Silvis, Marcel M Levi, Johanna A. Kremer Hovinga, Katarina Jood, Erik Lindgren et al. · 2021 · European Journal of Neurology
29. Vaccine-Induced Thrombocytopenia with Severe Headache
    Farid Salih, Linda Schönborn, Siegfried Kohler, Christiana Franke, Martin M. Möckel, Thomas Dörner, Hans-Christian Bauknecht, Christian Pille, Jan A. Graw, Angelika Alonso et al. · 2021 · New England Journal of Medicine
30. Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia
    Siyu Sun, Rolf T. Urbanus, Hugo Ten Cate, Philip G. de Groot, Bas de Laat, Johan W. M. Heemskerk, Mark Roest · 2021 · Cells
31. Non-Arteritic Anterior Ischemic Optic Neuropathy (NA-AION): A Comprehensive Overview
    Maria Letizia Salvetat, Francesco Pellegrini, Leopoldo Spadea, Carlo Salati, Marco Zeppieri · 2023 · Vision
32. Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia
    Karen L. Furie, Mary Cushman, Mitchell S.V. Elkind, Patrick D. Lyden, Gustavo Saposnik · 2021 · Stroke
33. B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
    Dennis Lapuente, Thomas Winkler, Matthias Tenbusch · 2023 · Cellular and Molecular Immunology
34. Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England
    William N. Whiteley, Samantha Ip, Jennifer Cooper, Thomas Bolton, Spencer J. Keene, Venexia M. Walker, Rachel Denholm, Ashley Akbari, Efosa Omigie, Sam Hollings et al. · 2022 · PLoS Medicine
35. COVID-19 vaccines: Considering sex differences in efficacy and safety
    Adelaide Jensen, Masha Strømme, Shayda Moyassari, Antonella Santuccione Chadha, Maria Carmela Tartaglia, Cassandra E. I. Szoeke, Maria Teresa Ferretti · 2022 · Contemporary Clinical Trials
36. COVID-19 vaccines adverse events: potential molecular mechanisms
    Malamatenia Lamprinou, Athanasios Sachinidis, Εleni Stamoula, Theofanis Vavilis, Georgios Papazisis · 2023 · Immunologic Research
37. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors
    Philipp von Hundelshausen, Reinhard L. Lorenz, Wolfgang Siess, Christian Weber · 2021 · Thrombosis and Haemostasis
38. Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
    Michael Makris, Sue R. Pavord, Will Lester, Marie Scully, Beverley Jane Hunt · 2021 · Research and Practice in Thrombosis and Haemostasis
39. Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia
    Emmanuel J. Favaloro · 2021 · International Journal of Laboratory Hematology
40. Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib
    Nichola Cooper, Waleed Ghanima, Quentin A. Hill, Phillip L.R. Nicolson, Vadim V. Markovtsov, Craig M. Kessler · 2022 · Platelets
41. Vaccines for COVID-19: Where do we stand in 2021?
    Ketaki Sharma, Archana Koirala, Katrina Nicolopoulos, Clayton Chiu, Nicholas Wood, Philip N Britton · 2021 · Paediatric Respiratory Reviews
42. Self-assembled polymeric micelle as a novel mRNA delivery carrier
    Jin Ren, Yiming Cao, Lei Li, Xin Wang, Haitao Lü, Jing Yang, Shengqi Wang · 2021 · Journal of Controlled Release
43. NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
    Halina Hoi Laam Leung, José Perdomo, Zohra Ahmadi, Shiying Silvia Zheng, Fairooj N. Rashid, Anoop Kumar Enjeti, Stephen B. Ting, James J.H. Chong, Beng H. Chong · 2022 · Nature Communications
44. Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
    Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, Bindra Patel, Anup Kumar, Sanjay Kumar Prasad, Bibhuti Bhusan Kakoti, Ajeet Kumar Kaushik, Mariya Jesawadawala · 2023 · Vaccines
45. COVID-19-Associated Cardiovascular Complications
    Clement C. E. Lee, Kashan Ali, David W. Connell, Ify R. Mordi, George Casella, Elizabeth MSL Lang, Chim Choy Lang · 2021 · Diseases
46. Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis
    Alessia Bignucolo, Lucia Scarabel, Silvia Mezzalira, Jerry Polesel, Erika Cecchin, Giuseppe Toffoli · 2021 · Vaccines
47. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia
    Christopher Jordan Patriquin, Vinçent Laroche, Rita Selby, Jacob M. Pendergrast, David S. Barth, Benoit Côté, Nathalie Gagnon, Guillaume Roberge, Marc Carrier, Lana A. Castellucci et al. · 2021 · New England Journal of Medicine
48. Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France
    Charmet, Tiffany, Schaeffer, Laura, Grant, Rebecca, Galmiche, Simon, Chény, Olivia, Von Platen, Cassandre, Maurizot, Alexandra, Rogoff, Alexandra, Omar, Faïza, David, Christophe et al. · 2021 · The Lancet Regional Health - Europe
49. Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT
    Adam J. Kanack, Antonios Bayas, Gemlyn George, Mouhamed Yazan Abou‐Ismail, Bandana Singh, Mindy Kohlhagen, Noah P. Splinter, Monika Christ, Markus K. Naumann, Karen A. Moser et al. · 2022 · Blood
50. Purposing plant-derived exosomes-like nanovesicles for drug delivery: patents and literature review
    Nicola Salvatore Orefice, Rossella Di Raimo, Davide Mizzoni, Mariantonia Logozzi, Stefano Fais · 2023 · Expert Opinion on Therapeutic Patents
51. COVID-19 mRNA Vaccine and Myocarditis
    Balraj Singh, Parminder Kaur, Leon Cedeno, Taulant Brahimi, Prem Patel, Hartaj Virk, Fayez E. Shamoon, Manesh Bikkina · 2021 · European Journal of Case Reports in Internal Medicine
52. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants
    John Charles Rotondo, Fernanda Martini, Martina Maritati, Chiara Mazziotta, Giulia Di Mauro, Carmen Lanzillotti, Nicole Barp, Altea Gallerani, Mauro G. Tognon, Carlo Contini · 2021 · Viruses
53. Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
    Talal M. Fael Al-Mayhani, Sadia Saber, Matthew James Stubbs, Nicholas A Losseff, Richard J. Perry, Robert J. Simister, David Gull, Hans Rolf Jäger, Marie Scully, David John Werring · 2021 · Journal of Neurology Neurosurgery & Psychiatry
54. Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism
    Piotr Rzymski, Bartłomiej Perek, Robert Flisiak · 2021 · Vaccines
55. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination
    Toshiaki Iba, Jerrold H. Levy · 2022 · Trends in Cardiovascular Medicine
56. Decline in Pathogenic Antibodies over Time in VITT
    Linda Schönborn, Thomas Thiele, Lars Kaderali, Andreas Greinacher · 2021 · New England Journal of Medicine
57. COVID-19 Vaccines: Adenoviral Vectors
    Catherine Jacob-Dolan, Dan H. Barouch · 2021 · Annual Review of Medicine
58. T cell immunity to SARS-CoV-2
    Julia Niessl, Takuya Sekine, Marcus Buggert · 2021 · Seminars in Immunology
59. Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration
    Leo Nicolai, Alexander Leunig, Kami Pekayvaz, Max Esefeld, Afra Anjum, Justina Rath, Eva Riedlinger, Vincent Ehreiser, Magdalena Mader, Luke Eivers et al. · 2022 · Blood
60. Acute myocardial infarction and myocarditis following COVID-19 vaccination
    Yin Nwe Aye, A S Mai, Audrey A. Y. Zhang, Oliver Zi-Hern Lim, Norman Lin, Caitlin Hsuen Ng, Mark Y. Chan, James Yip, P H Loh, Nicholas Chew · 2021 · QJM
61. Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective
    Abid A. Haseeb, Omar Mahmoud Solyman, Mokhtar Mohamed Ibrahim Abushanab, Ahmed S Abo Obaia, Abdelrahman M. Elhusseiny · 2022 · Vaccines
62. Perspectives on vaccine induced thrombotic thrombocytopenia
    Arad Dotan, Yehuda Shoenfeld · 2021 · Journal of Autoimmunity
63. Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: A Large-Scale Multinational Study Implementing Machine Learning Tools in Predicting Post-Vaccination Adverse Effects Based on Predisposing Factors
    Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin Naser Olaimat, Rohimah Mohamud, Mirna A. Fawaz, Elham Talib Kateeb, Omar K. Alkhairy, Reema Tayyem, Mohamed Lounis, Marwan Al‐Raeei et al. · 2022 · Vaccines
64. Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
    Lucía Bailón, Anuska Llano, Samandhy Cedeño, Tuixent Escribà, Míriam Rosás-Umbert, Mariona Parera, María Casadellà, Miriam Lopez, Francisco Pérez, Bruna Oriol-Tordera et al. · 2022 · Nature Medicine
65. Vaccine-induced immune thrombotic thrombocytopenia
    Douglas B. Cines, Andreas Greinacher · 2023 · Blood
66. Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure
    Linda Schönborn, Olga Esteban, Jan Wesche, Paulina Dobosz, Marta Broto, Sara Rovira Puig, Jessica Fuhrmann, Raquel Torres, Josep Serra, Roser Llevadot et al. · 2023 · Blood
67. Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
    Amir Abbas Shiravi, Ali Ardekani, Erfan Sheikhbahaei, Kiyan Heshmat‐Ghahdarijani · 2021 · Cardiology and Therapy
68. Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States
    Montano, Diego · 2022 · Frontiers in Public Health
69. Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors
    Judith Stickdorn, Lara Stein, Danielle Arnold-Schild, Jennifer Hahlbrock, Carolina Medina‐Montano, Joschka Bartneck, Tanja Ziß, Evelyn Montermann, Cinja Kappel, Dominika Hobernik et al. · 2022 · ACS Nano
70. Platelet-activating anti-PF4 disorders: An overview
    Theodore Earl Warkentin · 2022 · Seminars in Hematology
71. Treatment of drug-induced immune thrombocytopenias
    Irene Marini, Günalp Uzun, Kinan Jamal, Tamam Bakchoul · 2022 · Haematologica
72. Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score
    Jimin Hwang, Seung Hyun Park, Seung Won Lee, Se Bee Lee, Min Ho Lee, Gwang Hun Jeong, Min Seo Kim, Jong Yeob Kim, Ai Koyanagi, Louis Jacob et al. · 2021 · European Heart Journal
73. COVID ‐19: vaccination problems
    Harald Brüssow · 2021 · Environmental Microbiology
74. A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination
    Stefan Handtke, Martina Wolff, Carlo Zaninetti, Jan Wesche, Linda Schönborn, Konstanze Aurich, Lena Ulm, Nils-Olaf Hübner, Karsten Becker, Thomas Thiele et al. · 2021 · Blood
75. Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis
    Prakash Bhuyan, J. Medin, H. G. da Silva, Madhavi Yadavalli, Nirmal Kumar Shankar, H. Mullerova, M. Arnold, Magnus Nord · 2021 · The Lancet
76. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
    Heinz Ludwig, Pieter Sonneveld, Thierry T.F. Facon, Jesús F. San Miguel, Hervé Avet‐Loiseau, Mohamad Mohty, Maria-Victoria Mateos, Philippe Moreau, Michèle Cavo, Charlotte Pawlyn et al. · 2021 · The Lancet Haematology
77. Cardiovascular and haematological events post COVID‐19 vaccination: A systematic review
    Dana Al‐Ali, Abdallah Elshafeey, Malik Mushannen, Hussam Kawas, Ameena Shafiq, Narjis Mhaimeed, Omar Mhaimeed, Nada Mhaimeed, Rached Zeghlache, Mohammad A. Salameh et al. · 2021 · Journal of Cellular and Molecular Medicine
78. COVID-19 vaccination in pregnancy
    Erkan Kalafat, Paul Trafford Heath, Smriti Prasad, Pat O’Brien, Asma A. Khalil · 2022 · American Journal of Obstetrics and Gynecology
79. Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
    Yacine Maringer, Annika Nelde, Sarah M. Schroeder, Juliane Schuhmacher, Sebastian Hörber, Andreas Peter, Julia Karbach, Elke Jäger, Juliane S. Walz · 2022 · Science Immunology
80. Acute Macular Neuroretinopathy following Coronavirus Disease 2019 Vaccination
    Manuela Mambretti, Josef Christian Huemer, Giulia Torregrossa, Marlies Ullrich, Oliver Findl, Giuseppe Casalino · 2021 · Ocular Immunology and Inflammation
81. Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding
    Jakob Trimpert, Kristina Dietert, Theresa C. Firsching, Nadine Ebert, Tran Thi Nhu Thao, Daria Vladimirova, Susanne Kaufer, Fabien Labroussaa, Azza Abdelgawad, Andelé M. Conradie et al. · 2021 · Cell Reports
82. Controversy surrounding the Sputnik V vaccine
    Mario Cazzola, Paola Rogliani, Filomena Mazzeo, Maria Gabriella Matera · 2021 · Respiratory Medicine
83. SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence
    Elizabeth‐Barbara Tatsi, Filippos Filippatos, Athanasios G. Michos · 2021 · Epidemiology and Infection
84. Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens
    Lynda Coughlan, Eric J. Kremer, Dmitry M. Shayakhmetov · 2022 · Molecular Therapy
85. Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study
    Corinne Willame, Caitlin N. Dodd, Carlos E. Durán, RJHJ Elbers, Rosa Gini, Claudia Bartolini, Olga Paoletti, L Wang, Véra Ehrenstein, Johnny A. Kahlert et al. · 2022 · Vaccine
86. Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort
    Magunia, Harry, Lederer, Simone, Verbuecheln, Raphael, Gilot, Bryant Joseph, Koeppen, Michael, Haeberle, Helene A., Mirakaj, Valbona, Hofmann, Pascal, Marx, Gernot, Bickenbach, Johannes et al. · 2021 · Critical Care
87. Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines
    L. Palaiodimou, Maria-Ioanna Stefanou, A. Katsanos, Diana Aguiar de Sousa, J. Coutinho, P. Lagiou, I. Michopoulos, A. Naska, S. Giannopoulos, K. Vadikolias et al. · 2021 · Neurology
88. Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States
    Abanoub Riad, Andrea Pokorná, Mohamed K. Mekhemar, Jonas Conrad, Jitka Klugarová, Michal Koščík, Miloslav Klugar, Sameh Attia · 2021 · Vaccines
89. Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines
    Stephan Michalik, Florian Siegerist, Raghavendra Palankar, Kati Franzke, Maximilian Schindler, Alexander Reder, Ulrike Seifert, Clemens Cammann, Jan Wesche, Leif Steil et al. · 2022 · Haematologica
90. COVID‐19 and immunothrombosis: emerging understanding and clinical management
    Rebecca Shaw, Charlotte Ann Bradbury, Simon Timothy Abrams, Guozheng Wang, Cheng‐Hock Toh · 2021 · British Journal of Haematology
91. Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data
    Luigi Cari, Paolo Fiore, Mahdieh Naghavi Alhosseini, Gianni Sava, Giuseppe Nocentini · 2021 · Journal of Autoimmunity
92. Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
    Sverre Holm, Hassen Kared, Annika Elisabet Michelsen, Xiang Yi Kong, Tuva Børresdatter Dahl, Nina Haagenrud Schultz, Tuula A. Nyman, Cathrine Fladeby, Ingebjørg Seljeflot, Thor Ueland et al. · 2021 · European Heart Journal
93. Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England
    Nick J Andrews, Julia Stowe, Mary Elizabeth Ramsay, Elizabeth Miller · 2021 · The Lancet Regional Health - Europe
94. Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
    Andreas Greinacher, Linda Schönborn, Florian Siegerist, Leif Steil, Raghavendra Palankar, Stefan Handtke, Alexander Reder, Thomas Thiele, Konstanze Aurich, Karen Methling et al. · 2022 · Seminars in Hematology
95. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis
    Ah Young Kim, Wongi Woo, Dong Keon Yon, Seung Won Lee, Jae Won Yang, Ji Hong Kim, Seoyeon Park, Ai Koyanagi, Min Seo Kim, Sungsoo Lee et al. · 2022 · International Journal of Infectious Diseases
96. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond
    Andreas Greinacher, Theodore Earl Warkentin · 2023 · Hematology
97. SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia
    Ismaı̈l Elalamy, Grigoris Gerotziafas, Sonia Alamowitch, Jean-Pierre Laroche, Patrick Van Dreden, Walter Ageno, Jan Beyer‐Westendorf, Alexander Thomas Cohen, David Jiménez, Benjamin Brenner et al. · 2021 · Thrombosis and Haemostasis
98. Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine
    Lea Krutzke, Reinhild Rösler, Ellen Allmendinger, Tatjana Engler, Sebastian Wiese, Stefan Kochanek · 2022 · eLife
99. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US
    Xintong Li, Edward Burn, Talita Duarte‐Salles, Can Yin, Christian Reich, Antonella Delmestri, Katia M.C. Verhamme, Peter R. Rijnbeek, Marc A. Suchard, Kelly Li et al. · 2022 · BMJ
100. Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis
     David García‐Azorín, Thien Phu Do, Andreas R. Gantenbein, Jakob Møller Hansen, Marcio Nattan Portes Souza, Mark Obermann, Heiko Pohl, Christoph Josef Schankin, Henrik Winther Schytz, Alexandra Jean Sinclair et al. · 2021 · The Journal of Headache and Pain